questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the supply of Ozempic pens for patients with type 2 diabetes.
answerText: We are aware of a supply issue with glucagon-like peptide 1 receptor agonist (GLP-1 RA) medicines, including Ozempic pens. We have issued guidance in the form of Medicine Supply Notifications and, on 18 July 2023, issued a National Patient Safety Alert wi...
heading: Diabetes: Drugs